| 12404289 |
1′-cyano nucleoside analogs and uses thereof |
Daniel H. Byun, Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Petr Jansa, Rao V. Kalla +4 more |
2025-09-02 |
|
| 11939347 |
1′-cyano nucleoside analogs and uses thereof |
Daniel H. Byun, Byoung-Kwon Chun, Michael O'Neil Hanrahan Clarke, Petr Jansa, Rao V. Kalla +4 more |
2024-03-26 |
$240,166,000 |
| 11229638 |
Therapeutic heterocyclic compounds |
Mark J. Bartlett, Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel, Elfatih Elzein +4 more |
2022-01-25 |
$416,614,000 |
| 11179397 |
Imidazopyrimidine derivatives |
Gregory Chin, Michael O' Neil Hanrahan Clarke, Xiaochun Han, Tim Hansen, Yunfeng Eric Hu +6 more |
2021-11-23 |
$216,502,000 |
| 11040033 |
Therapeutic heterocyclic compounds |
Mark J. Bartlett, Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel, Elfatih Elzein +4 more |
2021-06-22 |
$444,628,000 |
| 10100058 |
Fused heterocyclic compounds as CaM kinase inhibitors |
Elfatih Elzein, Rao V. Kalla, Xiaofen Li, Eric Q. Parkhill, Thao Perry +3 more |
2018-10-16 |
$159,225,000 |
| 9695192 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Xiaofen Li +7 more |
2017-07-04 |
|
| 9682998 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +9 more |
2017-06-20 |
$270,182,000 |
| 9676760 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +7 more |
2017-06-13 |
$212,033,000 |
| 9598435 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +7 more |
2017-03-21 |
$500,566,000 |
| 9403782 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Michael Graupe, Juan A. Guerrero, Robert Jiang +9 more |
2016-08-02 |
$640,089,000 |
| 9371329 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Tetsuya Kobayashi +5 more |
2016-06-21 |
$611,992,000 |
| 9193694 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Xiaofen Li +7 more |
2015-11-24 |
$1,013,184,000 |
| 9115096 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Tetsuya Kobayashi +9 more |
2015-08-25 |
$514,598,000 |
| 9079901 |
Fused heterocyclic compounds as ion channel modulators |
Tetsuya Kobayashi, Gregory Notte, Eric Q. Parkhill, Jeff Zablocki |
2015-07-14 |
$595,814,000 |
| 8962610 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Xiaofen Li +7 more |
2015-02-24 |
$561,542,000 |
| 8952034 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Tetsuya Kobayashi +5 more |
2015-02-10 |
$366,812,000 |
| 8912190 |
Substituted heterocyclic compounds |
Eric Q. Parkhill, Jeff Zablocki |
2014-12-16 |
$916,490,000 |
| 8703759 |
Fused heterocyclic compounds as ion channel modulators |
Tetsuya Kobayashi, Gregory Notte, Eric Q. Parkhill, Jeff Zablocki |
2014-04-22 |
$736,470,000 |
| 8697863 |
Fused heterocyclic compounds as ion channel modulators |
Elfatih Elzein, Xiaofen Li, Jeff Zablocki, Chandrasekar Venkataramani |
2014-04-15 |
$344,444,000 |
| 8586732 |
Fused heterocyclic compounds as ion channel modulators |
Britton Kenneth Corkey, Elfatih Elzein, Robert Jiang, Rao V. Kalla, Xiaofen Li +7 more |
2013-11-19 |
$308,376,000 |
| 8148376 |
3, 4-dihydroquinoxalin-2(1H)-ones for use as stearoyl CoA desaturase inhibitors |
Jeffrey Chisholm, Jeff Zablocki, Eric Q. Parkhill, Andrey Glushkov, Natalya Vasilevich +2 more |
2012-04-03 |
$131,367,000 |
| 8143249 |
Prodrugs of A2B adenosine receptor antagonists |
Rao V. Kalla, Jeff Zablocki, Elfatih Elzein |
2012-03-27 |
$132,735,000 |
| 8088792 |
Triazolopyridinone derivatives for use as stearoyl CoA desaturase inhibitors |
Jeff Zablocki |
2012-01-03 |
$37,116,000 |
| 7893066 |
Pyridol[2,3-B]pyrazinones for use as stearoyl CoA desaturase inhibitors |
Jeff Zablocki, Eric Q. Parkhill, Andrei Glushkov, Natalya Vasilevich, Timur Zilbershtein +2 more |
2011-02-22 |
$88,974,000 |